Shares of Healthpeak Properties, Inc. (NYSE:DOC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twelve brokerages that are presently covering the firm, Marketbeat.com reports. Six investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $20.1818.
Several equities research analysts have issued reports on the company. Robert W. Baird dropped their target price on Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, November 12th. Raymond James Financial upgraded Healthpeak Properties from a “market perform” rating to an “outperform” rating and set a $20.00 price objective on the stock in a research note on Monday, September 15th. Cantor Fitzgerald initiated coverage on Healthpeak Properties in a report on Wednesday, October 1st. They set a “neutral” rating and a $20.00 price objective on the stock. Evercore ISI reduced their target price on Healthpeak Properties from $22.00 to $21.00 and set an “outperform” rating for the company in a report on Monday, December 15th. Finally, Wells Fargo & Company upped their price target on Healthpeak Properties from $18.00 to $19.00 and gave the company an “equal weight” rating in a research report on Tuesday, November 25th.
Healthpeak Properties Price Performance
Healthpeak Properties (NYSE:DOC – Get Free Report) last posted its quarterly earnings results on Thursday, October 23rd. The real estate investment trust reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The company had revenue of $705.87 million for the quarter, compared to analyst estimates of $681.65 million. Healthpeak Properties had a negative net margin of 1.36% and a negative return on equity of 0.44%. The company’s quarterly revenue was up .8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. Equities analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.
Healthpeak Properties Announces Dividend
The company also recently disclosed a monthly dividend, which was paid on Tuesday, December 30th. Investors of record on Friday, December 19th were paid a dividend of $0.1017 per share. The ex-dividend date of this dividend was Friday, December 19th. This represents a c) annualized dividend and a yield of 7.6%. Healthpeak Properties’s payout ratio is currently -2,440.00%.
Institutional Trading of Healthpeak Properties
Several institutional investors and hedge funds have recently bought and sold shares of the company. Mather Group LLC. purchased a new position in shares of Healthpeak Properties during the 3rd quarter valued at $25,000. City Holding Co. bought a new stake in Healthpeak Properties during the third quarter valued at $26,000. Sound Income Strategies LLC purchased a new position in Healthpeak Properties during the third quarter worth about $28,000. Rexford Capital Inc. bought a new position in Healthpeak Properties in the 2nd quarter worth about $28,000. Finally, Elevation Point Wealth Partners LLC bought a new position in Healthpeak Properties in the 2nd quarter worth about $32,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
About Healthpeak Properties
Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.
Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.
Recommended Stories
- Five stocks we like better than Healthpeak Properties
- The Best $1 You’ll Spend This Holiday Season
- Holiday surprise: $1 gets you everything
- America’s “most deplorable” Christmas sale
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- Your family’s wealth expires in 2026?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.
